Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
CRISPR QC Developing Electronic Platform to Measure Gene Editing Performance

CRISPR QC Developing Electronic Platform to Measure Gene Editing Performance

by Xcellerant Ventures | Jan 31, 2023 | Portfolio Company News

The blog was posted on CRISPR QC’s website: https://www.crisprqc.com/post/genomeweb-interview-of-ross-bundy-crispr-qc-ceo With $1.6 million of seed funding recently added to its balance sheet, CRISPR QC is advancing the commercial development of its data...
CRISPR QC Closes Seed Round at $1.6M and Appoints George Bonaros to Board of Directors

CRISPR QC Closes Seed Round at $1.6M and Appoints George Bonaros to Board of Directors

by Xcellerant Ventures | Jan 10, 2023 | Portfolio Company News

Press release origionally released on Business Wire:...
Next Entries »

Recent Posts

  • TruLite Health Partners with Lee Health to Elevate Health Equity Strategy
  • TruLite Health Selected for Microsoft Pegasus Program
  • Xcellerant Ventures Leads DeepLook Medical’s Series A Round
  • DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
  • Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023